Assoc. Prof. GÜNEŞ GÜNER GEBEŞ

Publication Network

Articles 43

1. Histopathology-based Artificial Intelligence Algorithms for the Prediction of Prostate Cancer Metastasis After Radical Prostatectomy

Cha E., Lin Z., Lu J., Oliveira L. D., Erak E., Mendes A. A., et al.

European Urology , vol.89, no.2, pp.140-148, 2026 (SCI-Expanded, Scopus)

2. Intratesticular Serous Borderline Tumor: A Clinicopathologic and Molecular Analysis of Four Tumors With Literature Review

Yildirim N. A., YAPRAK BAYRAK B., Turan G., ŞAHİN Ş., Kivrak H., Baran D. P., et al.

International Journal of Surgical Pathology , 2026 (SCI-Expanded, Scopus)

3. AKR1B1 Expression in the Colorectal Tumor Microenvironment Contributes Towards Its Prognostic Significance

DEMİRKOL CANLI S., GÜNER GEBEŞ G., Isik A., Sosic-Jurjevi B., Rom A. D., SEZA E. G., et al.

CANCER MEDICINE , vol.14, no.10, 2025 (SCI-Expanded, Scopus) Sustainable Development

4. Comparison of Pathologist and Artificial Intelligence-based Grading for Prediction of Metastatic Outcomes After Radical Prostatectomy

Oliveira L. D., Lu J., Erak E., Mendes A. A., Dairo O., ERTUNÇ O., et al.

EUROPEAN UROLOGY ONCOLOGY , no.1, pp.9-13, 2025 (SCI-Expanded, Scopus)

5. Testicular metastasis in prostate cancer: A rare case of testicular metastasis diagnosed with Ga-68-PSMA and review of the literature

ÖZYİĞİT G., AKDOĞAN B., YILMAZ M. T., GÜNER G., BOZKURT M. F.

JOURNAL OF CLINICAL UROLOGY , vol.17, no.1, pp.79-82, 2024 (ESCI, Scopus) Sustainable Development

6. Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images.

Erak E., Oliveira L. D., Mendes A. A., Dairo O., Ertunc O., Kulac I., et al.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc , vol.36, no.10, pp.100247, 2023 (SCI-Expanded, Scopus)

7. Claudin 18.2 Expression in Gastric Adenocarcinomas in a Large Turkish Cohort

Işık A., GÜNER G., Zeyneloğlu C., DEMİRKOL CANLI S., TAŞTAN H., AKYOL A.

Abant Tıp Dergisi , vol.12, no.2, pp.122-130, 2023 (Peer-Reviewed Journal)

8. Role of Reduced Bdnf Expression in Novel Apc Mutant Allele-induced Intestinal and Colonic Tumorigenesis in Mice

Gok A., Işik A., Bakir S., Uzun S., GÜNER G., Ozcan O., et al.

In Vivo , vol.37, no.4, pp.1562-1575, 2023 (SCI-Expanded, Scopus)

9. Characterization of the Subcellular Distribution of Phospho-β-catenin in Colorectal Cancer

Uzun S., Isik A., KATİPOĞLU K., GÜNER G., AKYOL A.

In Vivo , vol.37, no.4, pp.1576-1583, 2023 (SCI-Expanded, Scopus)

10. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer

Ozbek B., ERTUNÇ O., Erickson A., Vidal I. D., Gomes-Alexandre C., Guner G., et al.

PROSTATE , vol.82, no.6, pp.706-722, 2022 (SCI-Expanded, Scopus) Sustainable Development

11. Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer

Haffner M. C., Bhamidipati A., Tsai H. K., Esopi D. M., Vaghasia A. M., Low J., et al.

PROSTATE , vol.81, no.15, pp.1159-1171, 2021 (SCI-Expanded, Scopus) Sustainable Development

12. Enhanced expression of HNF4 alpha during intestinal epithelial differentiation is involved in the activation of ER stress

Tunçer S., Sade-Memişoğlu A., Keşküş A., Sheraj I., Güner G., Akyol A., et al.

FEBS JOURNAL , vol.287, no.12, pp.2504-2523, 2020 (SCI-Expanded, Scopus)

13. Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma

Eich M., Chaux A., Rodriguez M. A. M., GÜNER G., Taheri D., Pena M. D. C. R., et al.

HISTOPATHOLOGY , vol.76, no.3, pp.423-432, 2020 (SCI-Expanded, Scopus)

14. Effective targeting of RNA polymerase I in treatment-resistant prostate cancer

Low J., Sirajuddin P., Moubarek M., Agarwal S., Rege A., GÜNER G., et al.

PROSTATE , vol.79, no.16, pp.1837-1851, 2019 (SCI-Expanded, Scopus)

15. Tumor immune microenvironment in non-muscle-invasive urothelial carcinoma of the bladder

Eich M., Chaux A., GÜNER G., Taheri D., Rodriguez M. A. M., Pena M. D. C. R., et al.

HUMAN PATHOLOGY , vol.89, pp.24-32, 2019 (SCI-Expanded, Scopus)

16. Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations

Palsgrove D. N., Taheri D., Springer S. U., Cowan M., GÜNER G., Rodriguez M. A. M., et al.

HUMAN PATHOLOGY , vol.85, pp.1-9, 2019 (SCI-Expanded, Scopus)

17. Class III beta-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response

Oztop S., IŞIK A., GUNER G., Gurdal H., KARABULUT E., Yilmaz E., et al.

ANTICANCER RESEARCH , vol.39, no.2, pp.655-662, 2019 (SCI-Expanded, Scopus)

18. An immunohistochemical approach to detect oncogenic CTNNB1 mutations in primary neoplastic tissues

AKYOL A., GUNER G., OZSEKER H. S., IŞIK A., Atci O., UZUN S., et al.

LABORATORY INVESTIGATION , vol.99, no.1, pp.128-137, 2019 (SCI-Expanded, Scopus)

19. Morphologic and Immunohistochemical Appraisal of Primary Gastric Carcinomas

GUNER G., IŞIK A., KARABULUT E., GEDIKOGLU G., SÖKMENSÜER C., AKYOL A.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY , vol.26, no.10, 2018 (SCI-Expanded, Scopus)

20. Unusual Presentation of a Cutaneous Malignancy: Giant Merkel Cell Carcinoma with Intra-abdominal Metastasis

ÇALIŞ M., EKİN Ö., Memis P., GÜNER G., KARAKOÇ D., ELÇİN G., et al.

TURKISH JOURNAL OF PLASTIC SURGERY , vol.26, no.3, pp.131-134, 2018 (ESCI, Scopus)

21. Undifferentiated Embryonal Sarcoma of the Liver in an Adult Patient

Beksac K., Mammadov R., Ciftci T., GÜNER G., AKYOL A., Kaynaroglu V.

CUREUS , vol.10, no.7, 2018 (ESCI)

22. Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer

Haffner M. C., GÜNER G., Taheri D., Netto G. J., Palsgrove D. N., Zheng Q., et al.

AMERICAN JOURNAL OF PATHOLOGY , vol.188, no.6, pp.1478-1485, 2018 (SCI-Expanded, Scopus)

23. Professionalism in Pathology: The Turkish Experience

Güner G., Müderrisoğlu C., Kösemehmetoğlu K., Söylemezoğlu F.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE , vol.142, no.4, pp.433, 2018 (SCI-Expanded, Scopus)

24. Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization

Holdhoff M., GÜNER G., Rodriguez F. J., Hicks J. L., Zheng Q., Forman M. S., et al.

CLINICAL CANCER RESEARCH , vol.23, no.12, pp.3150-3157, 2017 (SCI-Expanded, Scopus)

25. Novel Assay to Detect RNA Polymerase I Activity In Vivo

GÜNER G., Sirajuddin P., Zheng Q., Bai B., Brodie A., Liu H., et al.

MOLECULAR CANCER RESEARCH , vol.15, no.5, pp.577-584, 2017 (SCI-Expanded, Scopus)

26. Cyanoacrylate Associated Foreign Body Granulomatous Gastritis: A Report of Three Cases

GÜNER G., KURTULAN O., KAV T., SÖKMENSÜER C., Gedikoglu G., AKYOL A.

CASE REPORTS IN PATHOLOGY , 2017 (ESCI)

27. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma

Nguyen D., Taheri D., Springer S., Cowan M., GÜNER G., Rodriguez M. A. M., et al.

VIRCHOWS ARCHIV , vol.469, no.4, pp.427-434, 2016 (SCI-Expanded, Scopus)

28. Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study

Ball M. W., Gorin M. A., GÜNER G., Pierorazio P. M., Netto G., Paller C. J., et al.

CLINICAL GENITOURINARY CANCER , vol.14, no.5, 2016 (SCI-Expanded, Scopus)

29. High-resolution telomere fluorescence in situ hybridization reveals intriguing anomalies in germ cell tumors

Shekhani M. T., Barber J. R., Bezerra S. M., Heaphy C. M., Roibon H. D. G., Taheri D., et al.

HUMAN PATHOLOGY , vol.54, pp.106-112, 2016 (SCI-Expanded, Scopus)

30. The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms

GÜNER G., Bishop J. A., Bezerra S. M., Taheri D., Zahavi D. J., Rodriguez M. A. M., et al.

HUMAN PATHOLOGY , vol.54, pp.184-188, 2016 (SCI-Expanded, Scopus)

31. Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder

Cowan M. L., Springer S., Nguyen D., Taheri D., GÜNER G., Rodriguez M. A. M., et al.

HUMAN PATHOLOGY , vol.53, pp.8-13, 2016 (SCI-Expanded, Scopus)

32. High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder

Cowan M., Springer S., Nguyen D., Taheri D., GÜNER G., Rodriguez M. A. M., et al.

MODERN PATHOLOGY , vol.29, no.5, pp.511-515, 2016 (SCI-Expanded, Scopus)

33. Primary amyloidosis presenting intrahepatic cholestasis and fulminant hepatic failure

Ates O., KÖSEMEHMETOĞLU K., Guner G., Bayraktar Y.

ITALIAN JOURNAL OF MEDICINE , vol.10, no.1, pp.71-73, 2016 (ESCI, Scopus)

34. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder*

Reis L. O., Taheri D., Chaux A., GÜNER G., Rodriguez M. A. M., Bivalacqua T. J., et al.

HUMAN PATHOLOGY , vol.47, no.1, pp.20-25, 2016 (SCI-Expanded, Scopus)

35. F-18-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer

Rowe S. P., Gage K. L., Faraj S. F., Macura K. J., Cornish T. C., Gonzalez-Roibon N., et al.

JOURNAL OF NUCLEAR MEDICINE , vol.56, no.7, pp.1003-1010, 2015 (SCI-Expanded, Scopus)

36. Assessment of Tumoral PD-L1 Expression and Intratumoral CD8+T Cells in Urothelial Carcinoma

Faraj S. F., Munari E., GÜNER G., Taube J., Anders R., Hicks J., et al.

UROLOGY , vol.85, no.3, 2015 (SCI-Expanded, Scopus)

37. Utility of uroplakin II expression as a marker of urothelial carcinoma

Tian W., GÜNER G., Miyamoto H., Cimino-Mathews A., Gonzalez-Roibon N., Argani P., et al.

HUMAN PATHOLOGY , vol.46, no.1, pp.58-64, 2015 (SCI-Expanded, Scopus) Sustainable Development

38. Cytomorphological Features of Atypical Teratoid/Rhabdoid Tumor: An Account of 12 Years' Experience

GÜNER G., Onder S., Soylemezoglu F.

DIAGNOSTIC CYTOPATHOLOGY , vol.42, no.10, pp.856-862, 2014 (SCI-Expanded, Scopus)

39. Two patients with marginal symptoms showing hyperthecosis at the edge of malignancy: Presentation of two cases

Beksac S., Selcuk I., BOYRAZ G., GÜNER G., TURĞAL M., USUBÜTÜN A.

JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION , vol.14, no.3, pp.182-185, 2013 (ESCI, Scopus, TRDizin)

40. Malakoplakia of prostate as a complication of transrectal needle biopsy

GÜNER G., AKDOĞAN B., BAYDAR D.

CANADIAN JOURNAL OF UROLOGY , vol.19, no.1, pp.6124-6127, 2012 (SCI-Expanded, Scopus)

41. Gluteal Calcinosis in a Patient With Undifferentiated Connective Tissue Disease: A Bulky Lesion Resected Surgically

Isik M., GÜNER G., Yesilkaya Y., Calguneri M.

TURKIYE FIZIKSEL TIP VE REHABILITASYON DERGISI-TURKISH JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION , vol.57, pp.358-360, 2011 (SCI-Expanded, TRDizin)

42. WWOX expression in prostatic adenocarcinoma

GÜNER G., Guler G., Huebner K., Baydar D. E.

VIRCHOWS ARCHIV , vol.459, 2011 (SCI-Expanded, Scopus)

43. Indian ink vs tissue marking dye: a quantitative comparison of two widely used macroscopical staining tool

Kosemehmetoglu K., Guner G., Ates D.

VIRCHOWS ARCHIV , vol.457, no.1, pp.21-25, 2010 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 6

1. Effect of platelet-rich fibrin on colonic anastomosis

Mahmudzada K., GÜNER G., DİNÇSOY A. B., KAŞIKCI M., ERDEM A., EROL T.

31st Biennial Congress of ISUCRS (International Society of University Colon and Rectal Surgeons), İstanbul, Turkey, 27 October 2022, (Summary Text)

2. Neoadjuvant randomized trial of degarelix (Deg) +/- cyclophosphamide/GVAX (Cy/GVAX) in men with high-risk prostate cancer (PCa) undergoing radical prostatectomy (RP).

Antonarakis E. S., Zahurak M., Schaeffer E. M., Partin A. W., Ross A., Allaf M., et al.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35, (Summary Text) Sustainable Development

3. TERT Promoter Mutations in Urinary Bladder Adenocarcinoma

Cowan M., Springer S., Nguyen D., Taheri D., GÜNER G., Mendoza Rodriguez M. A., et al.

105th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington, United States Of America, 12 - 18 March 2016, vol.96, (Summary Text)

4. TERT Promoter Mutations in Squamous Cell Carcinoma of the Bladder

Cowan M., Springer S., Nguyen D., Taheri D., Guner G., Mendoza Rodriguez M. A., et al.

105th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington, United States Of America, 12 - 18 March 2016, vol.29, (Summary Text)

5. TERT Promoter Mutations in Aggressive Variants of Urothelial Carcinoma

Nguyen D., Springer S., Cowan M., Taheri D., Guner G., Mendoza Rodriguez M. A., et al.

105th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington, United States Of America, 12 - 18 March 2016, vol.96, (Summary Text)

6. Indian ink vs tissue marking dye a quantitative comparison of two widely used macroscopical staining tool

KÖSEMEHMETOĞLU K., GÜNER G., ATEŞ D., SOYLU E.

Intercongress meeting of the European Society of Pathology, 31 August - 03 September 2010, vol.457, pp.199

Books 1

1. Mide kanseri ve prekürsör lezyonlar: Güncel ve moleküler sınıflama.

GÜNER TAŞ G., AKYOL A., GÜNER G.

in: Gastrointestinal Patolojide Yenilikler., Özdamar ŞO, Editor, Türkiye Klinikleri, Ankara, pp.22-28, 2019

Metrics

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

537

H-Index (WoS)

Citation (Scopus)

887

H-Index (Scopus)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works